BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19862822)

  • 1. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
    Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
    Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
    Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
    Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
    De Angelis PM; Clausen OP; Schjølberg A; Stokke T
    Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas.
    Larramendy ML; Tarkkanen M; Valle J; Kivioja AH; Ervasti H; Karaharju E; Salmivalli T; Elomaa I; Knuutila S
    Am J Pathol; 1997 Feb; 150(2):685-91. PubMed ID: 9033281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
    Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
    Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
    Nobusawa S; Stawski R; Kim YH; Nakazato Y; Ohgaki H
    Neuropathology; 2011 Dec; 31(6):583-8. PubMed ID: 21382095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
    Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
    Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
    Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
    J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.
    Speicher MR; Howe C; Crotty P; du Manoir S; Costa J; Ward DC
    Cancer Res; 1995 Mar; 55(5):1010-3. PubMed ID: 7866983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.
    Lambros MB; Fiegler H; Jones A; Gorman P; Roylance RR; Carter NP; Tomlinson IP
    J Pathol; 2005 Jan; 205(1):29-40. PubMed ID: 15586366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.